Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.006 mg/m³
Most sensitive endpoint:
irritation (respiratory tract)
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
90
Dose descriptor:
LOAEC
Value:
1 mg/m³
AF for dose response relationship:
3
Justification:
Since the starting point for the DNEL calculation is a LOAEL, a factor between 3 and 10 is suggested in ECHA Guidance Chapter R.8, 2012. In this case a factor 3 is chosen, because the effects at the low dose were slight, fully recovered with regard to the findings in BALF, and showed a tendency to recover after 4 weeks for the histopathology findings.
AF for differences in duration of exposure:
6
Justification:
Default factor for duration extrapolation subacute to chronic.
AF for interspecies differences (allometric scaling):
1
Justification:
According to ECHA Guidance Chapter R.8, 2012 allometric scaling should not be applied if the effects are not dependent on metabolic rate or systemic absorption, e.g. in the case of local effects, therefore AF 1 is chosen.
AF for other interspecies differences:
1
Justification:
A factor 2.5 is suggested by ECHA Guidance Chapter R.8, 2012 for remaining interspecies differences, but justified deviations are possible. For local effects on respiratory tract it should be taken into account that rodents like the rat are in general more sensitive compared to humans as the rat’s ventilation frequency is higher. Particular in the repeated dose 90-days study a local irritant effect on the rat larynx was observed, which is known to be a common finding in rat inhalation studies and which is seen as an indicator of the especially high susceptibility of the rodent larynx to any mild irritant (Kaufmann et al., Exp. Toxicol. Pathol. 61, 591 - 603, 2009). Also the other effects observed at the effect level were solely local or rat specific secondary effects and indicated on irritancy as the primary Mode of Action. Therefore a factor of 1 is applied.
AF for intraspecies differences:
5
Justification:
For workers, as standard procedure for threshold effects a default assessment factor of 5 is to be used.
AF for the quality of the whole database:
1
Justification:
The default assessment factor to be applied for good/standard quality of the database, taking into account completeness, consistency and the standard information requirements, is 1.
Acute/short term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.011 mg/m³
Most sensitive endpoint:
irritation (respiratory tract)
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
45
DNEL extrapolated from long term DNEL

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)
Most sensitive endpoint:
sensitisation (skin)
Acute/short term exposure
Hazard assessment conclusion:
high hazard (no threshold derived)

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

For workers in industrial settings, which are exposed to the substance via inhalation, DNELs for acute and long-term inhalation have to be derived. For this purpose the available, fully reliable, repeated inhalation toxicity study (OECD TG 412) provides the point of departure for the DNEL derivation, which is a LOAEC in this case. Consequently, an additional assessment factor for dose response relationship has to be used (i.e. factor 3).

The reproductive toxicity screening with gavage administration reveals no specific systemic toxicity and confirms the repeated inhalation toxicity study as the relevant study to be used for risk assessment in the workplace.

In addition, the possible risk of skin sensitization has to be assessed. Since it is not possible with the available data to calculate a threshold for skin sensitization a qualitative approach is used: with respect to skin sensitization the substance is allocated to the high hazard band (cp. ECHA Guidance Part E: Risk characterisation, 2012).

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population

No hazard is identified for the general population, since the substance is not used in the public domain and exposure of consumers is thus not to be expected.